Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, May 2022

Altmetric Badge

Mentioned by

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in Brain Behavior and Immunity (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.